Laia Paré Brunet

Our work isn’t just about innovation—it’s about impact. We are dedicated to developing cutting-edge diagnostic tools that help define the best therapeutic options for patients with cancer, helping them receive the most effective treatment. #WorldCancerDay #precisiononcology

Remarkable Milestones! 🎉 #HER2DX is on a roll, continuously adding valuable clinical evidence data! Here’s everything we’ve achieved so far—and we’re just getting started! Stay tuned for more advancements! 🚀 #HER2+ #precisiononology #breastcancer More: ow.ly/YKZm50TV7QN

On this day, we reaffirm our commitment to advancing research, innovation, and #precisiononcology. Every breakthrough brings us closer to better outcomes for #patients. #PrecisionOncology #Innovation #BreastCancerAwarenessMonth #HER2DX #DNADX #TNBCDX

📢Development and validation of #TNBCDX a new genomic biomarker for early-stage triple-negative breast cancer with an without pembrolizumab. Published in @Annals_Oncology annalsofoncology.org/article/S0923-… @prat_aleix @VHIO @Laiapb @fara_bm @RevealGenomics

🎉 Celebrating 4 amazing years today! This milestone is just the beginning, thanks to our visionary leadership, committed team, and everyone who trusts us. We are dedicated to transforming cancer care to benefit patients. 🚀 #breastcancer #HER2DX #DNADX #TNBCDX

#HER2DX makes its first appearance at #ESMO24! Dr @BarbaraPistill2 #precisiononcology #breastcancer #ESMO2024

⭐️⭐️⭐️⭐️⭐️We are proud to have one of the best among us. Our CSO & co-founder @prat_aleix has been recognized by @Forbes_es as one of the 100 best doctors in Spain. (Article in Spanish) ow.ly/51W350T9Jh2 #precisiononcology #HER2DX

@prat_aleix @Teresa_Gorria @hospitalclinic Moltes felicitats @Teresa_Gorria!!! 😘

Poster 74P - #ESMOBreast24 Assessing the Implementation of the #HER2DX Genomic Test in a Real-World Setting for HER2+ #breastcancer @CejalvoM @badamo20 👉🏻 #HER2DX is being used across multiple scenarios. The #HER2DX scores provides new insights for patients.

Poster 12P - #ESMOBreast24 Updated findings from the first prospective #HER2DX clinical decision impact study on early-stage #HER2+ #breastcancer @OlgaMartnezSez1 👉🏻#HER2DX influenced clinical management in early stages of HER2+, increasing physicians' confidence

This photo doesn't capture everyone, but it offers a glimpse into the remarkable women on our team. Each day, we passionately work to enhance and improve the lives of patients with #breastcancer Let’s build a more equal and just world! #InternationalWomensDay #WomensDay #IWD2024

Introducing the DEFINITIVE project: #HER2DX first prospective trial, led by @idibaps, conducted across 44 hospitals in a total of 7 European and associated countries. funded by European Commission’s key funding program for research and innovation👉🏻 ow.ly/bskq50QJs55

HER2DX to undergo first prospective trial in 7 🇪🇺 countries, supported by a 8M Horizon Europe grant. Congrats to the @RevealGenomics team and co-PIs @TomasPascualMD & @OlgaMartnezSez1 for initiating this important effort! biospace.com/article/releas…

@Nchic5 @prat_aleix @hospitalclinic Moltes felicitats Doctora! 😘

🎉 🎉 So happy to announce that my PhD thesis was accepted! 🕒The many hours of research & writing compensate for this exciting turning point as an oncologist. 🙏 I must give credit to mentor @prat_aleix, colleagues for their support throughout all these years. @hospitalclinic

Our CSO & co-founder, @prat_aleix received the National Research Award "Doctores Diz Pintado" His exceptional work, including our groundbreaking test #HER2DX, has earned him this prestigious honor. Read about his achievements! 👉🏻 ow.ly/aFFX50QuMxr #precisiononcology

🌟 Merry Christmas and Happy Holidays! 🎄 #precisiononcology #HER2DX #DNADX

#SABCS23 | Poster PO3-16-03 | Investigating #HER2DX genomic assay concordance within HER2-positive #breastcancer. @fara_bm @adawaksmd @stolaney1 @Otto_DFCI @LabPolyak @Laiapb @G_Villacampa @prat_aleix @esther_sanfeliu @AnaVivancosVHIO

More evidence of clinical utility of #HER2DX for patients with esrly-stage HER2-positive #breastcancer

Dr @JavierCortesMD on PHERGain study explaining our collaboration with @wearemedsir #HER2DX #breastcancer #precisiononcology #ESMO23

On #WorldBreastCancer Day, we reiterate our commitment to innovation and finding answers for patients; this is what guides our daily work. #BreastCancerAwarenessMonth #breastcancer #precisiononcology #HER2DX